| 07th week of 2021 patent applcation highlights part 8 |
| Patent application number | Title | Published |
|---|
| 20210045976 | POWDER-CONTAINING COMPOSITION, POWDER FOR AQUEOUS SOLVENT, AND PRODUCTION METHOD OF POWDER FOR AQUEOUS SOLVENT | 2021-02-18 |
| 20210045977 | TOPICAL SKIN FORMULATIONS | 2021-02-18 |
| 20210045978 | O/W EMULSION COMPRISING PHOTOCHEMICALLY STABLE 4-(TERT-BUTYL)-4-METHOXYDIBENZOYLMETHANE IN OIL DROPLETS SMALLER THAN 8 MICROMETERS | 2021-02-18 |
| 20210045979 | METHOD OF MAKING A CLEAR PERSONAL CARE COMPRISING MICROCAPSULES | 2021-02-18 |
| 20210045980 | Grip Enhancing Compositions, and Methods and Uses Thereof | 2021-02-18 |
| 20210045981 | Methods and Kits for Using Blocked 2-AA for Glycan Analysis | 2021-02-18 |
| 20210045982 | TOPICAL COMPOSITION | 2021-02-18 |
| 20210045983 | RETINOL REPLACEMENT IN SKIN TREATMENT | 2021-02-18 |
| 20210045984 | COSMETIC COMPOSITION FOR A FAST SWEAT EVAPORATION | 2021-02-18 |
| 20210045985 | ORGANIC COMPOUNDS | 2021-02-18 |
| 20210045986 | COMPOSITION FOR PREVENTION OR TREATMENT OF SKIN INFECTION | 2021-02-18 |
| 20210045987 | LIQUID PERSONAL CLEANSING COMPOSITION | 2021-02-18 |
| 20210045988 | RECOMBINANT NUCLEIC ACIDS ENCODING COSMETIC PROTEIN(S) FOR AESTHETIC APPLICATIONS | 2021-02-18 |
| 20210045989 | EYELINER PRODUCT AND METHOD THEREOF | 2021-02-18 |
| 20210045990 | DISPERSIBLE POWDER AND COSMETIC | 2021-02-18 |
| 20210045991 | VOLATILE OILY COMPOSITION | 2021-02-18 |
| 20210045992 | Stable Cosmetic Ink Composition | 2021-02-18 |
| 20210045993 | COSMETIC COMPOSITIONS | 2021-02-18 |
| 20210045994 | USE OF UV RESISTANT ACTIVE MATERIALS ON HAIR | 2021-02-18 |
| 20210045995 | USES OF EXTRACTS OF ISOCHRYSIS SP | 2021-02-18 |
| 20210045996 | MYRCIARIA DUBIA FRUIT EXTRACTS RICH IN ORGANIC ACIDS, COSMETIC COMPOSITIONS COMPRISING SAME AND COSMETIC USES THEREOF | 2021-02-18 |
| 20210045997 | AMINO-PYRIMIDINE SKELETAL MUSCLE MODULATORS | 2021-02-18 |
| 20210045998 | TRANSDERMAL AND/OR DERMAL DELIVERY OF LIPOPHILIC ACTIVE AGENTS | 2021-02-18 |
| 20210045999 | TRANSDERMAL COMPOSITIONS OF IBUPROFEN AND METHODS OF USE THEREOF | 2021-02-18 |
| 20210046000 | IMPLANTABLE POLYMERIC DEVICE FOR SUSTAINED RELEASE OF BUPRENORPHINE | 2021-02-18 |
| 20210046001 | PHARMACEUTICAL OPHTHALMIC COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF | 2021-02-18 |
| 20210046002 | AMELIORATION OF AUTOIMMUNE UVEITIS THROUGH BLOCKADE OF CSF1R | 2021-02-18 |
| 20210046003 | HEALTH DRINK COMPOSITION FOR PREVENTING LIVER DAMAGE CAUSED BY ALCOHOL WHILE PROVIDING EXCELLENT HANGOVER RELIEF | 2021-02-18 |
| 20210046004 | EFFERVESCENT POWDER DELIVERY SYSTEM | 2021-02-18 |
| 20210046005 | PROCESS FOR CREATING SOLID DISPERSIONS | 2021-02-18 |
| 20210046006 | EMULSION COMPOSITION | 2021-02-18 |
| 20210046007 | Sustained Release Olanzapine Formulations | 2021-02-18 |
| 20210046008 | ARTIFICIAL ANTIGEN PRESENTING CELLS HAVING A DEFINED AND DYNAMIC SHAPE | 2021-02-18 |
| 20210046009 | PROTECTING ORAL OVERDOSE WITH ABUSE DETERRENT IMMEDIATE RELEASE FORMULATIONS | 2021-02-18 |
| 20210046010 | TABLETS CONTAINING ARGININE AT HIGH CONCENTRATION | 2021-02-18 |
| 20210046011 | ARTICLES AND METHODS FOR ADMINISTRATION OF THERAPEUTIC AGENTS | 2021-02-18 |
| 20210046012 | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE AND SOLID PREPARATION | 2021-02-18 |
| 20210046013 | ENTERIC SOFTGEL CAPULES | 2021-02-18 |
| 20210046015 | DRUG DELIVERY SYSTEMS COMPRISING SOLID SOLUTIONS OF WEAKLY BASIC DRUGS | 2021-02-18 |
| 20210046016 | PRECISION CHEMICAL ABLATION AND TREATMENT OF TISSUES | 2021-02-18 |
| 20210046017 | NUTRITIONAL COMPOSITIONS OF NON-PSYCHOTROPIC CANNABINOIDS AND XANTHINES | 2021-02-18 |
| 20210046018 | RESVERATROL MEDICATION FOR THE TREATMENT OF OCULAR PAIN AND METHOD OF USE THEREOF | 2021-02-18 |
| 20210046019 | FORMULATIONS FOR IMPROVING THE DELIVERY OF HYDROPHOBIC AGENTS | 2021-02-18 |
| 20210046020 | REDUCED COENZYME Q10-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME | 2021-02-18 |
| 20210046021 | TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE | 2021-02-18 |
| 20210046022 | FORMULATIONS FOR THE TREATMENT OF OCULAR SURFACE DISEASES AND RELATED METHODS | 2021-02-18 |
| 20210046023 | PERSISTANT TOPICAL ANTIMICROBIAL COMPOSITIONS AND METHODS OF USING THE SAME | 2021-02-18 |
| 20210046024 | USE OF COLCHICINE TO INHIBIT TUMOR GROWTH AND METASTASES | 2021-02-18 |
| 20210046025 | Injection for Protecting Ischemic Myocardium and Preparation Method thereof | 2021-02-18 |
| 20210046026 | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE AND INFLAMMATORY DISEASES | 2021-02-18 |
| 20210046027 | Fatty Acid Synthase Inhibitor and Application Thereof | 2021-02-18 |
| 20210046028 | MITOFUSIN ACTIVATORS AND METHODS OF USE THEREOF | 2021-02-18 |
| 20210046029 | LEVODOPA AND CARBIDOPA INTESTINAL GEL AND METHODS OF USE | 2021-02-18 |
| 20210046030 | COMPOSITIONS AND METHODS FOR TREATMENT OF INSULIN RESISTANCE | 2021-02-18 |
| 20210046031 | THERAPEUTIC AGENTS FOR TREATING RESTLESS LEG SYNDROME | 2021-02-18 |
| 20210046032 | METALLO-LIOTHYRONINE | 2021-02-18 |
| 20210046033 | Injectable Nitrogen Mustard Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same | 2021-02-18 |
| 20210046034 | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF CONDITIONS RELATED TO AGING | 2021-02-18 |
| 20210046035 | COMBINATION METHODS AND COMPOSITIONS INCLUDING SLEEP THERAPEUTICS FOR TREATING MOOD | 2021-02-18 |
| 20210046036 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA | 2021-02-18 |
| 20210046037 | LOW ERUCTATION COMPOSITION AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE IN A SUBJECT WITH FISH ALLERGY/HYPERSENSITIVITY | 2021-02-18 |
| 20210046038 | A19-144, A2-73 and Certain Anticholinesterase Inhibitor Compositions and Method for Anti-Seizure Therapy | 2021-02-18 |
| 20210046039 | MEDICINAL COMPOSITIONS OF CANNABINOIDS AND XANTHINES | 2021-02-18 |
| 20210046040 | PAIN-RELIEVING TOPICAL COMPOSITIONS | 2021-02-18 |
| 20210046041 | DEVICE AND METHOD FOR ADMINISTERING AN ACTIVE INGREDIENT | 2021-02-18 |
| 20210046042 | SUBSTANCES AND COMPOSITIONS FOR THE USE IN THE TREATMENT OF ENDOMETRIOSIS AND ENDOMETRIOSIS ASSOCIATED SYMPTOMS | 2021-02-18 |
| 20210046043 | USE OF DAPHNETIN IN IMPROVING FUNCTION OF AORTIC ENDOTHELIAL CELL | 2021-02-18 |
| 20210046044 | USE OF (+)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE TO TREAT ADDICTIVE AND ALCOHOL-RELATED DISORDERS | 2021-02-18 |
| 20210046045 | METHODS AND COMPOSITIONS ASSOCIATED WITH THE GRANULOCYTE COLONY-STIMULATING FACTOR RECEPTOR | 2021-02-18 |
| 20210046046 | SELF-EMULSIFYING FORMULATIONS OF DIM-RELATED INDOLES | 2021-02-18 |
| 20210046047 | INTRATHECAL ADMINISTRATION OF LEVETIRACETAM | 2021-02-18 |
| 20210046048 | Artemisinin Derivatives | 2021-02-18 |
| 20210046049 | PHARMACEUTICAL COMBINATION FOR MOOD DISORDERS | 2021-02-18 |
| 20210046050 | STABLE AMORPHOUS FORM OF SACUBITRIL VALSARTAN TRISODIUM COMPLEX AND PROCESSES FOR PREPARATION THEREOF | 2021-02-18 |
| 20210046051 | OXYMETAZOLINE FOR THE TREATMENT OF ANO-RECTAL DISORDERS | 2021-02-18 |
| 20210046052 | PHARMACEUTICAL COMPOSITION CONTAINING ANTIFUNGAL AGENT AS ACTIVE INGREDIENT | 2021-02-18 |
| 20210046053 | USE AND COMPOSITION FOR TREATING MYASTHENIA GRAVIS AND OTHER MYASTHENIC SYNDROMES | 2021-02-18 |
| 20210046054 | Tacrolimus For Improved Treatment Of Transplant Patients | 2021-02-18 |
| 20210046055 | Tacrolimus For Improved Treatment Of Transplant Patients | 2021-02-18 |
| 20210046056 | Compounds for Treating Diseases Associated with a Mitochondrial Dysfunction | 2021-02-18 |
| 20210046057 | Beta-lactamase inhibitor and use thereof | 2021-02-18 |
| 20210046058 | MACROCYCLE AND COMPOSITION COMPRISING THEREOF | 2021-02-18 |
| 20210046059 | METHODS OF TREATING GASTROINTESTINAL STROMAL TUMORS | 2021-02-18 |
| 20210046060 | Methods for the Administration of Certain VMAT2 Inhibitors | 2021-02-18 |
| 20210046061 | METHODS AND COMPOSITIONS FOR TREATING HERPESVIRUS INDUCED CONDITIONS | 2021-02-18 |
| 20210046062 | 1,4-DIHYDROPYRIDINE COMPOSITIONS, METHODS OF MAKING AND USE | 2021-02-18 |
| 20210046063 | NOVEL COMBINATION OF CRIZOTINIB WITH CHLOROQUINE FOR INHIBITION OF DIVERSE LUNG TUMORS | 2021-02-18 |
| 20210046064 | Treatment of Neurodegenerative Conditions by Disruption of Rhes | 2021-02-18 |
| 20210046065 | Methods for Treating Antipsychotic-Induced Weight Gain | 2021-02-18 |
| 20210046066 | ACETATE SALT OF BUPRENORPHINE AND METHODS FOR PREPARING BUPRENORPHINE | 2021-02-18 |
| 20210046067 | BUPROPION AS A MODULATOR OF DRUG ACTIVITY | 2021-02-18 |
| 20210046068 | COMPOSITION AND METHOD FOR REDUCING THROMBOCYTOPENIA | 2021-02-18 |
| 20210046069 | PENTAFLUOROSULFANYL-SUBSTITUTED AMIDE DERIVATIVES, PREPARATION METHODS THEREOF AND MEDICAL USES THEREOF | 2021-02-18 |
| 20210046070 | LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS | 2021-02-18 |
| 20210046071 | TETRACYCLIC COMPOUNDS AND THEIR SALTS, COMPOSITIONS, AND METHODS FOR THEIR USE | 2021-02-18 |
| 20210046072 | COMBINATION OF AN INHIBITOR OF PARP WITH AN INHIBITOR OF GSK-3 OR DOT1L | 2021-02-18 |
| 20210046073 | 2,3-DISUBSTITUTED 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS | 2021-02-18 |
| 20210046074 | INHIBITORS OF IMMUNE CHECKPOINT MODULATORS AND RELATED METHODS | 2021-02-18 |
| 20210046075 | QUINOLINE ANALOGS AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS | 2021-02-18 |
| 20210046076 | N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALING PATHWAY | 2021-02-18 |
